Table 1.
Socio-demographic and clinical characteristics of the study population (N = 971).
| Variable | N (%) |
|---|---|
| Age (years) | |
| <50 | 172 (17.7%) |
| 50–60 | 397 (40.9%) |
| >60 | 402 (41.4%) |
| Gender | |
| Male | 452 (46.5%) |
| Female | 519 (53.5%) |
| BMI (kg/m 2 ) | |
| Normal: <25 | 72 (7.4%) |
| Overweight: 25–29.9 | 297 (30.6%) |
| Obese: ≥30 | 602 (62.0%) |
| Waist circumference (cm) | |
| (M < 94, F < 80) | 88 (9.1%) |
| (M ≥ 94, F ≥ 80) | 883 (90.9%) |
| Marital status | |
| Married | 826 (85.1%) |
| Single | 32 (3.3%) |
| Divorced/ widow | 113 (11.6%) |
| Occupational status | |
| Employed | 236 (24.3%) |
| Not employed | 735 (75.7%) |
| Monthly income (JD) | |
| < 300 | 294 (30.3%) |
| 301–500 | 344 (35.4%) |
| >500 | 333 (34.3%) |
| Diabetes duration (years) | |
| >10 | 462 (47.6%) |
| ≤ 10 | 509 (52.4%) |
| Diabetes treatment | |
| Oral Hypoglycemic agents (OHA) | 501 (51.6) |
| Insulin only | 30 (3.1%) |
| Insulin + OHA | 440 (45.3%) |
| Statin duration (years) | |
| >5 | 420 (53.5%) |
| ≤ 5 | 365(46.5%) |
| Smoking | |
| Yes | 266 (27.4%) |
| No | 705 (72.6 %) |
| Level of education | |
| High school or less | 453 (46.7%) |
| More than high school | 518 (53.3%) |
| Received anti-dyslipidemia agent | 882 (84.7%) |
| Statins | 782 (80.5%) |
| Fibrates | 104 (10.7%) |
| Statin-fibrate combination | 92 (9.5%) |
| Ezetimibe | 2 (0.2%) |
| Omega-3 | 172 (17.7%) |
| Comorbidities | |
| Hypertension | 662 (68.2%) |
| Ischemic heart disease | 182 (18.7%) |
| Hypothyroidism | 127 (13.1%) |
| At least one comorbidity | 729 (75.1%) |
| Diabetes complications | |
| Retinopathy | 234 (24.1%) |
| Neuropathy | 266 (27.4%) |
| Nephropathy | 147 (15.1%) |
| At least one complication | 458 (47.2%) |